nipradilol has been researched along with arginine vasopressin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akaishi, M; Anzai, T; Baba, A; Handa, S; Mitamura, H; Nishimura, H; Ogawa, S; Yoshikawa, T | 1 |
1 trial(s) available for nipradilol and arginine vasopressin
Article | Year |
---|---|
Early reduction of neurohumoral factors plays a key role in mediating the efficacy of beta-blocker therapy for congestive heart failure.
Topics: Adrenergic beta-Antagonists; Arginine Vasopressin; Atrial Natriuretic Factor; Carteolol; Female; Heart Failure; Humans; Lymphocytes; Male; Middle Aged; Myocardial Contraction; Norepinephrine; Propanolamines; Receptors, Adrenergic, beta; Renin-Angiotensin System; Time Factors; Ventricular Function, Left | 1996 |